Concerning neuroprotective therapy for Parkinson's disease

R. J. Uitti, Zbigniew K Wszolek

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Studying potential neuroprotective therapy for Parkinson's disease is conceptually problematic because of the heterogenous nature of the Parkinson's syndrome and complexities in operational definitions for neuroprotection. The current literature concerning neuroprotection provides no convincing evidence of any treatment as definitively neuroprotective in Parkinson's disease. Recent clinical trials and novel trial designs are reviewed that may identify meaningful therapy, resulting in maintenance of neurological function and quality of life for persons with Parkinson's disease.

Original languageEnglish (US)
Pages (from-to)433-437
Number of pages5
JournalJournal of Neural Transmission, Supplement
Issue number70
StatePublished - 2006

Fingerprint

Parkinson Disease
Therapeutics
Maintenance
Quality of Life
Clinical Trials
Neuroprotection

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Concerning neuroprotective therapy for Parkinson's disease. / Uitti, R. J.; Wszolek, Zbigniew K.

In: Journal of Neural Transmission, Supplement, No. 70, 2006, p. 433-437.

Research output: Contribution to journalArticle

@article{06981f056a4a4794acd7ab649ae178ff,
title = "Concerning neuroprotective therapy for Parkinson's disease",
abstract = "Studying potential neuroprotective therapy for Parkinson's disease is conceptually problematic because of the heterogenous nature of the Parkinson's syndrome and complexities in operational definitions for neuroprotection. The current literature concerning neuroprotection provides no convincing evidence of any treatment as definitively neuroprotective in Parkinson's disease. Recent clinical trials and novel trial designs are reviewed that may identify meaningful therapy, resulting in maintenance of neurological function and quality of life for persons with Parkinson's disease.",
author = "Uitti, {R. J.} and Wszolek, {Zbigniew K}",
year = "2006",
language = "English (US)",
pages = "433--437",
journal = "Journal of Neural Transmission, Supplement",
issn = "0303-6995",
publisher = "Springer Wien",
number = "70",

}

TY - JOUR

T1 - Concerning neuroprotective therapy for Parkinson's disease

AU - Uitti, R. J.

AU - Wszolek, Zbigniew K

PY - 2006

Y1 - 2006

N2 - Studying potential neuroprotective therapy for Parkinson's disease is conceptually problematic because of the heterogenous nature of the Parkinson's syndrome and complexities in operational definitions for neuroprotection. The current literature concerning neuroprotection provides no convincing evidence of any treatment as definitively neuroprotective in Parkinson's disease. Recent clinical trials and novel trial designs are reviewed that may identify meaningful therapy, resulting in maintenance of neurological function and quality of life for persons with Parkinson's disease.

AB - Studying potential neuroprotective therapy for Parkinson's disease is conceptually problematic because of the heterogenous nature of the Parkinson's syndrome and complexities in operational definitions for neuroprotection. The current literature concerning neuroprotection provides no convincing evidence of any treatment as definitively neuroprotective in Parkinson's disease. Recent clinical trials and novel trial designs are reviewed that may identify meaningful therapy, resulting in maintenance of neurological function and quality of life for persons with Parkinson's disease.

UR - http://www.scopus.com/inward/record.url?scp=33750352533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750352533&partnerID=8YFLogxK

M3 - Article

C2 - 17017564

AN - SCOPUS:33750352533

SP - 433

EP - 437

JO - Journal of Neural Transmission, Supplement

JF - Journal of Neural Transmission, Supplement

SN - 0303-6995

IS - 70

ER -